All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration has sent a letter to drugmaker Roche warning that it must immediately stop referring to its HIV fusion inhibitor, Fuzeon, as having "100% antiviral activity," The Wall Street Journal reports. The FDA says a salesperson for the company made the claim during a medical conference in Washington, D.C. Roche was ordered to stop making the claim that Fuzeon is 100% effective and to stop disseminating or using educational or marketing materials that might have been used by the salesperson who made the initial claim. FDA officials say studies have shown 46% of HIV patients have some response to the drug, not the 100% the Roche salesperson claimed.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
Meet all 37 of the queer women in this season's WNBA
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
Here are the 15 gayest travel destinations in the world: report
Trending Stories & News
For more news and videos on advocatechannel.com, click here.